These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 29147991)

  • 61. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis.
    Shahi SK; Ghimire S; Lehman P; Mangalam AK
    Front Immunol; 2022; 13():966417. PubMed ID: 36164343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Disease-Modifying Therapies on Gut-Brain Axis in Multiple Sclerosis.
    Del Negro I; Pez S; Versace S; Marziali A; Gigli GL; Tereshko Y; Valente M
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38276041
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the Intestinal Microbiome of Italian Patients with Multiple Sclerosis and Their Household Relatives.
    Galluzzo P; Capri FC; Vecchioni L; Realmuto S; Scalisi L; Cottone S; Nuzzo D; Alduina R
    Life (Basel); 2021 Jun; 11(7):. PubMed ID: 34206853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
    Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
    Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
    Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
    Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gut-brain communication in demyelinating disorders.
    Sauma S; Casaccia P
    Curr Opin Neurobiol; 2020 Jun; 62():92-101. PubMed ID: 32066076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bifidobacteria: A probable missing puzzle piece in the pathogenesis of multiple sclerosis.
    Toghi M; Bitarafan S; Kasmaei HD; Ghafouri-Fard S
    Mult Scler Relat Disord; 2019 Nov; 36():101378. PubMed ID: 31487552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut environmental factors and multiple sclerosis.
    Miyake S; Yamamura T
    J Neuroimmunol; 2019 Apr; 329():20-23. PubMed ID: 30077395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis:
    Maiuolo J; Musolino V; Gliozzi M; Carresi C; Scarano F; Nucera S; Scicchitano M; Oppedisano F; Bosco F; Macri R; Palma E; Muscoli C; Mollace V
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An introduction to the microbiome and MS.
    Trott S; King IL
    Mult Scler; 2018 Jan; 24(1):53-57. PubMed ID: 29307298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Shahi SK; Freedman SN; Murra AC; Zarei K; Sompallae R; Gibson-Corley KN; Karandikar NJ; Murray JA; Mangalam AK
    Front Immunol; 2019; 10():462. PubMed ID: 30984162
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis.
    Wasko NJ; Nichols F; Clark RB
    Autoimmun Rev; 2020 Jan; 19(1):102430. PubMed ID: 31734400
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases.
    Mangalam AK; Ochoa-Repáraz J
    Front Immunol; 2020; 11():565305. PubMed ID: 33042145
    [No Abstract]   [Full Text] [Related]  

  • 80. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
    Xu L; Zhang C; He D; Jiang N; Bai Y; Xin Y
    Life Sci; 2020 Jul; 253():117747. PubMed ID: 32376270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.